L
Lumiata
Predictive analytics to provide better health care
About Lumiata
Lumiata operates in the healthcare analytics sector, leveraging artificial intelligence to predict costs and manage risks for healthcare providers and insurers. The company utilizes a vast repository of over 100 million patient records, 35 thousand physician curation hours, and 50 million articles mined from PubMed to generate deep insights. Lumiata's core products include AI models for predicting high-cost healthcare claims, disease onset, and group costs. The platform serves data scientists, healthcare professionals, and HR managers by providing tools for data preparation, cleansing, and model building. Lumiata's business model revolves around offering subscription-based access to its AI-powered analytics platform, enabling clients to make informed decisions and drive better outcomes. The company generates revenue through these subscriptions and additional services such as data enrichment and customization of AI models.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2013
- Headquarters
- San Mateo, United States
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 61.6/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Telecommunications, Risk Management, Analytics, Predictive Analytics
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Machine Learning, Deep Learning, Nanotech
- Business model
- SaaS
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Apr 2022 | $0 | — | Somatus | ↗ |
| SERIES B✓Equity / VC | Jan 2021 | $14M | $56M | Khosla Ventures · Blue Venture Fund · Defy Partners · AllegisCyber Capital | — |
Growth signals
Latest recorded traffic for Lumiata is 90 monthly website visits, down 93.6% over the last three months. Lumiata's team declined 92.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Castor Ventures
Alumni Ventures
Series A9 investors entered at this stage
Khosla Ventures
Sandbox Industries
BlueCross BlueShield Venture Partners
Intel Capital
Blue Cross and Blue Shield Association
Blue Venture Fund
Defy Partners
Allegis Capital
AllegisCyber Capital
Other known investors3 additional known investors
Somatus
Benjamin Ling
Plug and Play
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lumiata on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lumiata’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.